FDA Clearance Tracker · P230035
AGENT Paclitaxel-Coated Balloon Catheter
Last checked: Nov 20, 2026Latest source record: Feb 29, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 29, 2024
Approved
Time to decision
147 days
Received Oct 5, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P230035
- Device name
- AGENT Paclitaxel-Coated Balloon Catheter
- Applicant
- Boston Scientific Corporation
- Applicant location
- Maple Grove, MN
- Received
- Oct 5, 2023
- Decided
- Feb 29, 2024
- Decision
- Approved
- Supplements
- 8 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
The AGENT Paclitaxel-Coated Balloon Catheter is intended to be used after appropriate vessel preperation in adult patients undergoing percutaneous coronary intervention (PCI) in coronary arteries 2.0 mm to 4.0 mm in diameter and lesions up to 26 mm in length for the purpose of improving myocardial perfusion when treating in-stent restenosis (ISR).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code OOB (Drug-eluting percutaneous transluminal coronary angioplasty catheter).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
K261153 · Decided Aug 26, 2026 · 140 days after receipt
Device type: Ureteroscope And Accessories, Flexible/Rigid (FGB) · GI, Urology & Nephrology
K261915 · Decided Aug 4, 2026 · 56 days after receipt
Device type: Endoscopic Access Overtube, Gastroenterology-Urology (FED) · GI, Urology & Nephrology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.